Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An invasive breast carcinoma characterized by the presence of tubular and glandular neoplastic cell structures, admixed with islands of neoplastic cells showing squamous differentiation.
No clinical trials have been registered for adenosquamous breast carcinoma.
19 publications have been identified in PubMed for adenosquamous breast carcinoma. Research spans Review / Meta-Analysis (37%), Case Report / Case Series (26%), and Basic Science / Preclinical (21%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 7 | 37% |
Patient case studies | 5 |
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 12:51 AM UTC
Common questions about adenosquamous breast carcinoma
Laboratory research | 4 | 21% |
Clinical study results | 2 | 11% |
Disease patterns and progression | 1 | 5% |
Zou J (2025). [PMID: 40946394](https://pubmed.ncbi.nlm.nih.gov/40946394/). *J Surg Res*. [Epidemiology / Natural History]
Dennaoui R (2025). [PMID: 40624726](https://pubmed.ncbi.nlm.nih.gov/40624726/). *Breast Cancer Res*. [Basic Science / Preclinical]
Xing X (2025). [PMID: 40104510](https://pubmed.ncbi.nlm.nih.gov/40104510/). *Front Oncol*. [Review / Meta-Analysis]
Georgescu TA (2025). [PMID: 41301002](https://pubmed.ncbi.nlm.nih.gov/41301002/). *Cancers (Basel)*. [Review / Meta-Analysis]
Bizzarri N (2025). [PMID: 40328196](https://pubmed.ncbi.nlm.nih.gov/40328196/). *Int J Gynecol Cancer*. [Clinical Trial Publication]
Xu H (2025). [PMID: 40568576](https://pubmed.ncbi.nlm.nih.gov/40568576/). *Front Immunol*. [Review / Meta-Analysis]
Ogawa R (2025). [PMID: 39980511](https://pubmed.ncbi.nlm.nih.gov/39980511/). *Case Rep Oncol*. [Case Report / Case Series]
An R (2025). [PMID: 40032413](https://pubmed.ncbi.nlm.nih.gov/40032413/). *Zhonghua Bing Li Xue Za Zhi*. [Case Report / Case Series]
Li K (2025). [PMID: 39793300](https://pubmed.ncbi.nlm.nih.gov/39793300/). *Drug Resist Updat*. [Basic Science / Preclinical]
Yoshino R (2025). [PMID: 40041638](https://pubmed.ncbi.nlm.nih.gov/40041638/). *Cureus*. [Case Report / Case Series]